We are writing this editorial shortly after returning from Seoul, Korea, where we represented the Society of Toxicology (SOT) at the 13th International Congress of Toxicology (ICT). Our participation in this meeting served as an important reminder of two notable ways in which SOT contributes to and is perceived by toxicologists around the world. First, as the largest professional society of toxicologists in the world, we are expected to publish high-quality science that has gone through critical review in this and other scientific journals. Second, through our science, we are expected to be engaged if not leading the discussion of topical matters. In this editorial we want to address these two challenges presented to SOT and discuss how to work proactively to bring our science to bear on contemporary issues.
With respect to scientific publications, we believe that the members of SOT are responsible for disseminating relevant, high-quality science. Toward this end, Toxicological Sciences is publishing primary research articles, as well as featuring various toxicology-related topics through other mechanisms such as forum series to disseminate relevant, high-quality science. A few select examples include a forum series on toxicity testing in the 21st century Krewski, 2009, 2010) and publishing some of the early seminal research assessing the toxicity of nanomaterials (Dreher, 2004) and the mechanistic determination of the renal toxicity of melamine (Dobson et al., 2008) . In the timely but somewhat contentious area of mechanisms and testing paradigms for endocrine disrupting chemicals (EDCs), nearly 800 papers on this controversial subject have been published in Toxicological Sciences (from a total of 4650 total published papers) in the past 15 years. (Results based on a search of Toxicological Sciences, which searched for "endocrine disrupt*" from January 1998 through June 2013. Results were reviewed for accuracy and relevance and compared with the total number of papers published in the journal during this same time period.)
On the other hand, we as members of SOT must ask ourselves whether SOT as a scientific society is doing enough to set the standard for how toxicologists work proactively to bring our science to bear on contemporary issues. Our opinion on this important question is simply no: as a scientific society we have been mostly bystanders when it comes to contributing to the discussion of important issues of human and environmental safety.
Throughout its more than 50-year history, SOT has worked to develop consensus among its constituent groups that include scientists in academia, government, industry, consultancies, and nongovernment organizations. Although we are proud of this spirit of inclusion and mutual respect, it has frequently limited our ability to weigh in on matters of important scientific and societal concern. The SOT website lists 10 position statements during our 50-year history, including 3 focused on the use of animals in research, with 7 others covering subjects such as the public access policy of Toxicological Sciences, policies on the use of human subjects in toxicology research, and the integration of toxicology into regulatory science (http://www. toxicology.org/ms/is.asp). A few others have tackled more controversial issues such as genetically modified foods (GMO), and more recently, the Society has developed commentary designed to inform the general public and policy makers on the human and environmental issues arising from the Horizon Deep Water oil spill and a very current statement on the critical role that toxicology should play in the debate over the process of hydraulic fracturing. Accordingly, there are really only two Society-endorsed issue statements (distinguished from policies), namely one on chlorine toxicity and regulation issued in 1994 and the other on the safety of GMO foods released in 2002. Some may believe that this is too many issue statements-that we should remain on the sidelines of such matters; others may believe that we can and should do more.
Although individual members may speak out on controversial issues, the Society has remained relatively silent on such matters. However, it is becoming increasingly clear that although it toxicological sciences 136(1), 1-3 2013 doi:10.1093/toxsci/kft201 Advance Access publication September 5, 2013 may be "safe" to stay on the sidelines-providing limited or no scientific perspective in matters that are of significant concern and relevance to toxicology-this approach is actually harmful to our credibility and reputation. If we are the experts, we need to contribute to advancing the recognition of how our science can and should be used. Ultimately, SOT needs to become more proactively engaged in such discourse to ensure that sound science is used in all matters of safety evaluation and regulation.
We have a current opportunity to proactively show that SOT and the science of toxicology can bring scientific expertise, rational thinking, and objectivity to matters of societal importance. In particular, as the Chemical Safety Improvement Act of 2013 (reform of the 1976 Toxic Substance Control Act [TSCA] legislation; S.1009) proceeds through the U.S. Congress, we need to reach out to our policy makers to help them understand the applications and implications of the legislation and to provide relevant perspective on how to bring the best science to bear on the final law. A Task Force, comprised of SOT members with diverse expertise and experience, is in place to carry out this work, and we look forward to the opportunity to communicate with congressional staffers and key congressmen as the law moves through the legislative process. Although the Society is working proactively to provide a voice for our science in the TSCA reform legislation, we have missed a number of other opportunities to bring good science to bear on toxicology issues. A case in point is the ongoing debate regarding the safety and regulation of EDCs. As noted above, nearly 20% of all papers published in Toxicological Sciences since 1998 have focused on some aspect of research concerning the mode of action of EDCs. Additionally, there are now decisions pending from the European Commission regarding a regulatory framework for the evaluation and regulation of this class of compounds. This legislation is proposing to classify chemicals exhibiting endocrine activity as "Substances of Very High Concern," a classification historically reserved by the European Commission primarily for agents that produce certain forms of mutagenicity and genotoxic carcinogenicity. The consequence of this classification is the assumption a priori that there is no threshold for adverse effects unless the existence of a threshold can be proven experimentally. At best, demonstrating a threshold for compounds that exhibit endocrine-like activity represents an exceptionally high bar.
Others would argue that this is an insurmountable obstacle, as proof of a slope of "zero" would need to be demonstrated over a given range of concentrations/doses with respect to a biological response, irrespective of the inherent variability that exists within any biological system used for making such an argument. Moreover, as pointed out by Dietrich et al. (2013) in a recent editorial, "Regulations that profoundly affect human activities, that legally impose significant fines and even detention, should not be based on irrelevant tests forced to be regarded as relevant by administrative dictates, and on arbitrary default assumptions of no thresholds." Here is an example where SOT should be bringing scientific expertise using the best quality and most current science to the debate. In fact, toxicologists have probed and debated the concept of thresholds in adverse effects for many years, and our collective experience and expertise is highly relevant to the regulation of chemicals deemed to be potential EDCs.
We are not suggesting that SOT should advocate a particular opinion, but we must be strong advocates for applying the best science to such issues. SOT needs to strive to provide globally recognized expertise, which helps inform decision makers to craft regulatory policies that are balanced across different opinions yet based on sound science. We use the EDC issue specifically as an example as it was the very issue for which other groups criticized our methods, our science, and our relevance (Letter to Science, 2011a), and we believe such criticism is largely misrepresented, misguided, and unwarranted. Although SOT did respond to this criticism on one occasion (Letter to Science, 2011b), we have seemingly opted to "play it safe" by mostly staying on the sidelines. In the end, we believe that playing it safe has been detrimental to our science and to the Society.
If we are to be true to our vision to "create a safer and healthier world," then we must engage in scientific dialogue and discussion, and we must demonstrate that our science is rigorous and relevant on matters of societal interest, concern, and importance. Despite the challenge of preparing cogent documents that reflect the diversity of opinions on important subject matters, the Society needs to demonstrate that we have the expertise and objectivity to provide leadership on matters regarding human and environmental risk assessment. As a professional society of more than 7500 members, we may not always agree, but if such disagreements are carried out objectively and respectfully, they are likely to highlight the strengths and weaknesses of the science. The ability to promote and practice civil discourse on controversial issues is paramount to the Society. The objective presentation of the diversity of opinions or interpretations may help to education decision and policy makers on the range of certainty (or uncertainty) surrounding an important issue. It follows that if we can effectively communicate the strengths and weaknesses of the science, we can ultimately contribute to how the broader community outside of SOT understands and applies our science.
In that spirit, this Editorial is a call to our membership to speak out on relevant toxicology issues and encourage our Society to respond more regularly and vigorously on matters where the toxicology community should have a voice. We can engage in debate, and we can allow for different opinions to be voiced and supported, but we cannot remain silent.
Our vision to create a safer and healthier world applies to the world outside of the SOT. To achieve that vision, we must avoid playing it safe with our science.
